PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest.

Purpose: Peptide receptor radionuclide therapy (PRRT) is effective for metastatic/inoperable neuroendocrine tumors (NETs). Imaging response assessment is usually efficient subsequent to treatment completion. Blood biomarkers such as PRRT Predictive Quotient (PPQ) and NETest are effective in real-tim...

Full description

Bibliographic Details

Published in:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 47; no. 4; pp. 895 - 907
Main Authors:	Bodei, Lisa, Kidd, Mark S., Singh, Aviral, van der Zwan, Wouter A., Severi, Stefano, Drozdov, Ignat A., Malczewska, Anna, Baum, Richard P., Kwekkeboom, Dik J., Paganelli, Giovanni, Krenning, Eric P., Modlin, Irvin M.
Format:	Journal Article
Published:	Springer Nature Apr2020
Online Access:	View this record in EBSCOhost